Who
Tony T. Kalajian
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Beyond Meat; Sr.VP/Chief Accounting Officer, Insight Molecular Diagnostics.
In numbers
- Trades disclosed
- 9
- Buys
- 2
- Sells
- 0
- Bought
- $26K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 13 Sep 2019
- Last trade
- 10 May 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 May 2026filed 2 Jun 2026 | BYND Beyond Meatoption or derivative · Food Products | SEC FORM 4 Code A | —236,221 at $0.00 | filing |
| 10 May 2026filed 2 Jun 2026 | BYND Beyond Meatoption or derivative · Food Products | SEC FORM 4 Code A | —236,221 at $0.00 | filing |
| 10 May 2026filed 12 May 2026 | BYND Beyond MeatFood Products | SEC FORM 4 Code A | —180,051 at $0.00 | filing |
| 10 May 2026filed 12 May 2026 | BYND Beyond Meatoption or derivative · Food Products | SEC FORM 4 Code A | —237,718 at $0.00 | filing |
| 10 May 2026filed 12 May 2026 | BYND Beyond Meatoption or derivative · Food Products | SEC FORM 4 Code A | —237,718 at $0.00 | filing |
| 10 May 2026filed 12 May 2026 | BYND Beyond MeatFood Products | SEC FORM 4 Code A | —180,051 at $0.00 | filing |
| 3 Aug 2020filed 5 Aug 2020 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Bought | $6,5505,000 at $1.31 | filing |
| 10 Feb 2020filed 12 Feb 2020 | IMDX Insight Molecular Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —204,000 at $0.00 | filing |
| 13 Sep 2019filed 16 Sep 2019 | IMDX Insight Molecular DiagnosticsDiagnostics & Labs | SEC FORM 4 Bought | $20K10,000 at $1.98 | filing |
News
Oncocyte (NASDAQ:IMDX) and Alnylam Pharmaceuticals (NASDAQ:ALNY) Critical SurveyIMDX · tickerreport.com · 14 Oct 2026Reviewing Aktis Oncology (NASDAQ:AKTS) and Oncocyte (NASDAQ:IMDX)IMDX · tickerreport.com · 7 Oct 2026
0 headlines in the last 90 days name Tony T. Kalajian; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.